glp-1 pediatric How young is too young for GLP-1s? Bariatric surgery? Academic experts offer insights GLP-1 RAs emerge as promising

Medicamentos encontrados nas chamadas canetas emagrecedoras, como a liraglutida (Saxenda e Victoza), a semaglutida (Ozempic, Wegovy e Rybelsus) e a tirzepatida (Mounjaro e Zepbound), so classificados como agonistas ou anlogos de GLP-1

Retatrutide includes GLP-1 receptor activity, but it is designed as a triple agonist that also targets GIP and glucagon receptors

Compounded drugs are not FDA-approved

Structural basis for ligand recognition of incretin receptors

By enhancing insulin secretion and reducing glucagon levels, these drugs help maintain blood sugar within target ranges and reduce the risk of diabetes-related complications

The medications in this class include semaglutide, sold as Ozempic for diabetes and Wegovy for weight loss, and tirzepatide, sold as Mounjaro for diabetes and Zepbound for weight management